Papillary renal cell carcinoma treatment explained

Papillary renal cell carcinoma is a type of kidney cancer named for the way some tumour cells look under a microscope. Imaging helps show whether the growth is limited to the kidney or has reached nearby tissues or distant sites. A biopsy is sometimes used when its result will change management, although surgery may provide the main tissue diagnosis. Kidney function, the condition of the other kidney, symptoms, and inherited cancer concerns can all influence planning. A small localised tumour presents different choices from cancer that cannot be removed completely.

For a localised tumour, surgery may remove part or all of the affected kidney. Kidney removal surgery can be open or minimally invasive, and preserving working kidney tissue may be considered when suitable. Tumour ablation uses heat or cold to destroy a selected growth and may suit some people who are not having an operation. If disease has spread or returned, immunotherapy and targeted therapy may be discussed, sometimes in combination or sequence. Your team may arrange scans and blood tests before choosing a route, then monitor kidney function and treatment effects.

Tell your oncology team about worsening pain, visible blood in the urine, persistent fever, marked tiredness, or unexplained weight change. After an operation or ablation, urgent assessment is needed for heavy bleeding, inability to pass urine, severe abdominal or flank pain, breathlessness, chest pain, or a high fever. During medicines, report new rash, severe diarrhoea, yellowing of the skin, confusion, or breathing difficulty quickly because these can signal a treatment reaction.

Is my tumour confined to the kidney? Can kidney tissue be preserved? Why do you recommend surgery or ablation? What would immunotherapy or targeted therapy aim to do? How will treatment affect kidney function? Which symptoms require same-day advice?